SeaCrest Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$468K Sell
6,782
-4,456
-40% -$308K 0.05% 336
2025
Q1
$780K Sell
11,238
-278
-2% -$19.3K 0.09% 223
2024
Q4
$991K Sell
11,516
-5,947
-34% -$512K 0.1% 185
2024
Q3
$2.08M Sell
17,463
-73
-0.4% -$8.69K 0.22% 82
2024
Q2
$2.5M Buy
17,536
+475
+3% +$67.8K 0.28% 54
2024
Q1
$2.19M Sell
17,061
-106
-0.6% -$13.6K 0.27% 63
2023
Q4
$1.82M Buy
17,167
+3,083
+22% +$327K 0.22% 90
2023
Q3
$1.28M Buy
14,084
+3,032
+27% +$276K 0.17% 118
2023
Q2
$894K Buy
11,052
+1,482
+15% +$120K 0.11% 190
2023
Q1
$761K Buy
9,570
+2,058
+27% +$164K 0.1% 221
2022
Q4
$508K Buy
7,512
+1,544
+26% +$104K 0.07% 316
2022
Q3
$297K Buy
5,968
+652
+12% +$32.4K 0.05% 430
2022
Q2
$296K Sell
5,316
-30
-0.6% -$1.67K 0.04% 468
2022
Q1
$297K Buy
5,346
+940
+21% +$52.2K 0.03% 508
2021
Q4
$247K Sell
4,406
-66
-1% -$3.7K 0.03% 577
2021
Q3
$215K Sell
4,472
-304
-6% -$14.6K 0.03% 606
2021
Q2
$200K Buy
+4,776
New +$200K 0.02% 650
2020
Q1
Sell
-6,996
Closed -$202K 561
2019
Q4
$202K Buy
+6,996
New +$202K 0.03% 505
2019
Q2
Sell
-7,956
Closed -$208K 1402
2019
Q1
$208K Buy
7,956
+230
+3% +$6.01K 0.04% 450
2018
Q4
$178K Sell
7,726
-138
-2% -$3.18K 0.04% 458
2018
Q3
$185K Buy
7,864
+1,006
+15% +$23.7K 0.03% 530
2018
Q2
$158K Buy
6,858
+62
+0.9% +$1.43K 0.03% 575
2018
Q1
$167K Buy
6,796
+220
+3% +$5.41K 0.03% 541
2017
Q4
$176K Buy
+6,576
New +$176K 0.03% 541